DrugPatentWatch Database Preview
ACZONE Drug Profile
see a sample report or, see our see our flat-rate plans
Which patents cover Aczone, and what generic alternatives are available?
Aczone is a drug marketed by Allergan and Allergan Inc and is included in two NDAs. There are two patents protecting this drug and one Paragraph IV challenge.
This drug has fifteen patent family members in thirteen countries.
The generic ingredient in ACZONE is dapsone. There are eight drug master file entries for this compound. Fifteen suppliers are listed for this compound. Additional details are available on the dapsone profile page.
Summary for ACZONE
| International Patents: | 15 |
| US Patents: | 2 |
| Applicants: | 2 |
| NDAs: | 2 |
| Suppliers / Packagers: | 2 |
| Bulk Api Vendors: | 97 |
| Clinical Trials: | 13 |
| Patent Applications: | 3,785 |
| Formulation / Manufacturing: | see details |
| Drug Prices: | Drug price information for ACZONE |
| Patent Litigation and PTAB cases: | See patent lawsuits and PTAB cases for ACZONE |
| DailyMed Link: | ACZONE at DailyMed |
Medical Subject Heading (MeSH) Categories for ACZONE
Synonyms for ACZONE
| (4-sulfanilylphenyl)amine |
| 1,1'-Sulfonylbis(4-aminobenzene) |
| 1,1'-Sulfonylbis[4-aminobenzene] |
| 1,1'-Sulphonylbis(4-aminobenzene) |
| 1,1''-sulfonylbis(4-aminobenzene) |
| 1246638-15-2 |
| 1358F |
| 4 4-Diamino Diphenyl Sulfone 99.5%min Cas:80-08-8 |
| 4 inverted exclamation marka-Diaminodiphenyl sulfone |
| 4 inverted exclamation marka-Sulfonyldianiline |
| 4-(4-amino-benzenesulfonyl)-phenylamine |
| 4-(4-aminobenzenesulfonyl)aniline |
| 4-(4-aminophenyl)sulfonylaniline |
| 4-[(4-aminobenzene)sulfonyl]aniline |
| 4-[(4-aminophenyl)sulfonyl]aniline |
| 4-[(4-Aminophenyl)sulfonyl]phenylamine |
| 4-[(4-Aminophenyl)sulfonyl]phenylamine # |
| 4-Aminop henyl sulfone |
| 4-Aminophenyl sulfone |
| 4-Aminophenyl sulfone, 97% |
| 4-Aminophenylsulfone |
| 4,4 inverted exclamation marka-Diaminodiphenyl sulfone; 4,4 inverted exclamation marka-Sulfonyldianiline; Bis(4-aminophenyl) sulfone; Dapsone |
| 4,4`-DiaminoDiphenylSulphone |
| 4,4-Diaminodifenylsulfon |
| 4,4-Diaminodifenylsulfon [Czech] |
| 4,4-Diaminodiphenyl Sulfone |
| 4,4-Diaminodiphenylsulfone |
| 4,4-Sulfonyldianiline |
| 4,4' Diaminophenyl Sulfone |
| 4,4'-Dapsone |
| 4,4'-DDS |
| 4,4'-diamino diphenyl sulphone |
| 4,4'-Diaminodiphenyl sulfone |
| 4,4'-Diaminodiphenyl sulphone |
| 4,4'-Diaminodiphenyl suphone |
| 4,4'-Diaminodiphenylsulfone |
| 4,4'-diaminophenyl sulfone |
| 4,4'-Sulfonylbis-benzenamine |
| 4,4'-Sulfonylbis[benzamine] |
| 4,4'-Sulfonylbisaniline |
| 4,4'-Sulfonylbisbenzamine |
| 4,4'-Sulfonylbisbenzenamine |
| 4,4'-Sulfonylbisbenzeneamine |
| 4,4'-Sulfonyldianilin |
| 4,4'-Sulfonyldianiline |
| 4,4'-Sulfonyldianiline (Dapsone) |
| 4,4'-Sulfonyldiphenylamine |
| 4,4'-Sulphonylbisbenzamine |
| 4,4'-Sulphonylbisbenzenamine |
| 4,4'-Sulphonyldianiline |
| 4,4''-dapsone |
| 4,4''-diaminodiphenyl sulfone |
| 4,4''-sulfonylbisaniline |
| 4,4''-Sulfonylbisbenzenamine |
| 4,4''-sulfonyldianiline |
| 4'-Diaminodiphenyl sulfone |
| 80-08-0 |
| 8W5C518302 |
| A839828 |
| AB00051962 |
| AB00051962_19 |
| AB1004833 |
| AC-10922 |
| AC1L1EUH |
| AC1Q51WM |
| AC1Q51WN |
| ACMC-209piw |
| ACT07431 |
| Aczone (TN) |
| AI3-08087 |
| AK175100 |
| AKOS000119322 |
| ALBB-005917 |
| Ambap80-08-0 |
| AN-24011 |
| Aniline, 4,4'-sulfonyldi- |
| Aniline,4'-sulfonyldi- |
| ANW-37350 |
| Araldite HT |
| Araldite HT 976 |
| Atrisone |
| Avlosulfon |
| Avlosulfone |
| Avlosulphone |
| Avsulfor |
| AZT + Dapsone cominbation |
| BBL002412 |
| BDBM50029764 |
| Benzenamine, 4,4'-sulfonylbis- |
| Benzenamine,4'-sulfonylbis- |
| BIDD:GT0770 |
| BIS SULFONE |
| Bis(4-aminophenyl) sulfone |
| Bis(4-aminophenyl)sulfone |
| Bis(4-aminophenyl)sulphone |
| Bis(p-aminophenyl) sulfone |
| Bis(p-aminophenyl)sulphone |
| BPBio1_000143 |
| BRD-K62363391-001-05-8 |
| BRN 0788055 |
| BSPBio_000129 |
| BSPBio_002129 |
| C07666 |
| CAS-80-08-0 |
| CBDivE_013582 |
| CCG-40260 |
| CCRIS 192 |
| CD0112 |
| CHEBI:4325 |
| CHEMBL1043 |
| CJ-00109 |
| CPD000059064 |
| Croysulfone |
| Croysulphone |
| CS-2928 |
| CTK5E7438 |
| D SS |
| D00592 |
| D0089 |
| D0MA9N |
| DADPS |
| Dapsoderm-X |
| Dapson |
| Dapson-Fatol |
| Dapsona |
| Dapsona [INN-Spanish] |
| dapsone |
| Dapsone (USP) |
| Dapsone [USAN:BAN] |
| Dapsone [USAN:USP:INN:BAN] |
| Dapsone-d8 |
| Dapsone, European Pharmacopoeia (EP) Reference Standard |
| Dapsone, pharmaceutical secondary standard; traceable to USP, PhEur, BP |
| Dapsone, United States Pharmacopeia (USP) Reference Standard |
| Dapsone, VETRANAL(TM), analytical standard |
| Dapsonum |
| Dapsonum [INN-Latin] |
| DB00250 |
| DDS |
| DDS (pharmaceutical) |
| DDS, diaphenylsulfone |
| DDS, pharmaceutical |
| Di(4-aminophenyl) sulfone |
| Di(4-aminophenyl)sulfone |
| Di(4-aminophenyl)sulphone |
| Di(p-aminophenyl) sulfone |
| Di(p-aminophenyl)sulphone |
| Diamino-4,4'-diphenyl sulfone |
| Diamino-4,4'-diphenyl sulphone |
| Diamino-diphenyl sulphone |
| Diaminodifenilsulfona |
| Diaminodifenilsulfona [Spanish] |
| Diaminodiphenyl sulfone |
| Diaminodiphenylsulfone |
| Dianiline, 4,4'-sulfonyl- |
| Diaphenyl sulfone |
| Diaphenylsulfon |
| Diaphenylsulfone |
| Diaphenylsulfone (JAN) |
| diaphenylsulfone; |
| Diaphenylsulphon |
| Diaphenylsulphone |
| Dimitone |
| Diphenasone |
| Diphone |
| Disulone |
| DivK1c_000573 |
| DSS (VAN) |
| DSSTox_CID_371 |
| DSSTox_GSID_20371 |
| DSSTox_RID_75547 |
| DTXSID4020371 |
| Dubronax |
| Dubronaz |
| Dumitone |
| EBD28910 |
| EC 201-248-4 |
| EINECS 201-248-4 |
| Eporal |
| F 1358 |
| F0266-3067 |
| Fatol Brand of Dapsone |
| FT-0624447 |
| Hardener HT 976 |
| HMS1568G11 |
| HMS1920C14 |
| HMS2091K04 |
| HMS2095G11 |
| HMS2231G09 |
| HMS3259C13 |
| HMS3369B11 |
| HMS501M15 |
| HSDB 5073 |
| HT 9664 |
| HT 976 |
| HY 976 |
| HY-B0688 |
| I01-3640 |
| IDI1_000573 |
| IN-201 |
| KB-105651 |
| KBio1_000573 |
| KBio2_001368 |
| KBio2_003936 |
| KBio2_006504 |
| KBio3_001349 |
| KBioGR_000900 |
| KBioSS_001368 |
| KS-00000JP1 |
| KS-1450 |
| KSC647I3R |
| LS-1790 |
| LS10738 |
| MCULE-7294380437 |
| Metabolite C |
| Mex-America Brand of Dapsone |
| MFCD00007887 |
| MLS000069409 |
| MLS001055349 |
| MLS001076146 |
| MolPort-001-780-172 |
| MQJKPEGWNLWLTK-UHFFFAOYSA-N |
| N, N'-Diphenyl sulfondiamide |
| N,N'-Diphenyl sulfondiamide |
| N'-Diphenyl sulfondiamide |
| NC00488 |
| NCGC00016322-01 |
| NCGC00016322-02 |
| NCGC00016322-03 |
| NCGC00016322-04 |
| NCGC00016322-05 |
| NCGC00016322-06 |
| NCGC00016322-07 |
| NCGC00016322-08 |
| NCGC00016322-09 |
| NCGC00016322-10 |
| NCGC00016322-13 |
| NCGC00023946-03 |
| NCGC00023946-04 |
| NCGC00023946-05 |
| NCGC00023946-06 |
| NCGC00254533-01 |
| NCGC00258899-01 |
| NCI-C01718 |
| NINDS_000573 |
| Novophone |
| NSC 6091 |
| NSC 6091D |
| NSC-6091 |
| NSC-756716 |
| NSC6091 |
| NSC756716 |
| Opera_ID_1950 |
| Oprea1_143052 |
| OR020157 |
| OR175241 |
| OR342946 |
| Orsade Brand of Dapsone |
| p-Aminophenyl sulfone |
| p, p'-Sulfonyldianiline |
| p,p-Diaminodiphenyl sulphone |
| p,p-Sulfonylbisbenzamine |
| p,p-Sulfonylbisbenzenamine |
| p,p-Sulphonylbisbenzamine |
| p,p-Sulphonylbisbenzenamine |
| p,p-Sulphonyldianiline |
| p,p'-Diaminodiphenyl sulfone |
| p,p'-sulfonyldianiline |
| p,p''-diaminodiphenyl sulfone |
| Pharmakon1600-01500222 |
| Prestwick_152 |
| Prestwick0_000035 |
| Prestwick1_000035 |
| Prestwick2_000035 |
| Prestwick3_000035 |
| Protogen |
| Q-200435 |
| R1186 |
| RP28805 |
| RTR-025382 |
| s4612 |
| SAM002554879 |
| SBB003168 |
| SBI-0051331.P003 |
| SC-46793 |
| SCHEMBL21428 |
| Servidapson |
| Slphadione |
| SMR000059064 |
| SPBio_001025 |
| SPBio_002050 |
| Spectrum_000888 |
| SPECTRUM1500222 |
| Spectrum2_001133 |
| Spectrum3_000375 |
| Spectrum4_000310 |
| Spectrum5_000825 |
| SR-01000002976 |
| SR-01000002976-2 |
| ST50308134 |
| STK387118 |
| Sulfadione |
| Sulfanona-mae |
| Sulfon-mere |
| Sulfona |
| Sulfona-MAE |
| Sulfone ucb |
| Sulfone, 4,4'-Diaminophenyl |
| Sulfone, diphenyl, 4,4'-diamino- |
| Sulfonyldianiline |
| Sulphadione |
| Sulphon-mere |
| Sulphonyldianiline |
| Sumicure S |
| Tarimyl |
| TL8005401 |
| Tox21_110371 |
| Tox21_110371_1 |
| Tox21_201347 |
| Tox21_300558 |
| Udolac |
| UNII-8W5C518302 |
| W R 448 |
| WLN: ZR DSWR DZ |
| WR 448 |
| ZB000637 |
| ZINC6310 |
US Patents and Regulatory Information for ACZONE
| Applicant | Tradename | Generic Name | Dosage | NDA | Approval Date | TE | Type | RLD | RS | Patent No. | Patent Expiration | Product | Substance | Delist Req. | Exclusivity Expiration |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Allergan | ACZONE | dapsone | GEL;TOPICAL | 021794-001 | Jul 7, 2005 | AB | RX | Yes | Yes | ➤ Sign Up | ➤ Sign Up | ➤ Sign Up | |||
| Allergan Inc | ACZONE | dapsone | GEL;TOPICAL | 207154-001 | Feb 24, 2016 | RX | Yes | Yes | ➤ Sign Up | ➤ Sign Up | ➤ Sign Up | ||||
| Allergan Inc | ACZONE | dapsone | GEL;TOPICAL | 207154-001 | Feb 24, 2016 | RX | Yes | Yes | ➤ Sign Up | ➤ Sign Up | ➤ Sign Up | ||||
| Applicant | Tradename | Generic Name | Dosage | NDA | Approval Date | TE | Type | RLD | RS | Patent No. | Patent Expiration | Product | Substance | Delist Req. | Exclusivity Expiration |
see a sample report or, see our see our flat-rate plans
Expired US Patents for ACZONE
| Applicant | Tradename | Generic Name | Dosage | NDA | Approval Date | Patent No. | Patent Expiration |
|---|---|---|---|---|---|---|---|
| Allergan Inc | ACZONE | dapsone | GEL;TOPICAL | 207154-001 | Feb 24, 2016 | ➤ Sign Up | ➤ Sign Up |
| Allergan | ACZONE | dapsone | GEL;TOPICAL | 021794-001 | Jul 7, 2005 | ➤ Sign Up | ➤ Sign Up |
| Allergan | ACZONE | dapsone | GEL;TOPICAL | 021794-001 | Jul 7, 2005 | ➤ Sign Up | ➤ Sign Up |
| Applicant | Tradename | Generic Name | Dosage | NDA | Approval Date | Patent No. | Patent Expiration |
Paragraph IV (Patent) Challenges for ACZONE
| Drugname | Dosage | Strength | RLD | Date |
|---|---|---|---|---|
| ➤ Subscribe | Gel | 7.5% | ➤ Subscribe | ➤ Sign Up |
see a sample report or, see our see our flat-rate plans
